Marion Alcantara

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Image cytometry differentiates CD34+ and CD133+ profiles of very small embryonic-like stem cells.

Image cytometry differentiates CD34+ and CD133+ profiles of very small embryonic-like stem cells.

Journal: Cell transplantation

Published: February 19, 2026

Early-phase trials of in vivo CAR: International insights and pathways for the French framework

Early-phase trials of in vivo CAR: International insights and pathways for the French framework

Journal: Bulletin du cancer

Published: November 20, 2025

The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM.

The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM.

Journal: Cell

Published: July 28, 2025

Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.

Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.

Journal: Journal of hematology & oncology

Published: October 19, 2024

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.

Journal: Journal of hematology & oncology

Published: July 31, 2024

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 25, 2024

Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study.

Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study.

Journal: Neurology

Published: June 03, 2024

Optimizing efficacy and security of CAR-T cells, and immune monitoring

Optimizing efficacy and security of CAR-T cells, and immune monitoring

Journal: Medecine sciences : M/S

Published: May 31, 2024

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.

Journal: American journal of hematology

Published: November 27, 2023

First line treatments in primary central nervous system lymphomas in young patients.

First line treatments in primary central nervous system lymphomas in young patients.

Journal: Current opinion in oncology

Published: July 27, 2023

Human kidney-derived hematopoietic stem cells can support long-term multilineage hematopoiesis.

Human kidney-derived hematopoietic stem cells can support long-term multilineage hematopoiesis.

Journal: Kidney international

Published: April 28, 2022

Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.

Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.

Journal: Blood cancer journal

Published: September 02, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026